Thursday, December 2, 2010

http://bcca0okcyrlcu3fso4ih-mbk9m.hop.clickbank.net/


A researcher from the De Montfort University in Leicester, England has developed new technology destined to change the face of diabetes management in the years to come.
Professor Joan Taylor has developed an artificial pancreas that can prove to be the demise of daily insulin injections diabetics have endured to regulate glucose levels in the body.
Diabetics suffer from insulin insufficiency and thus are unable to regulate the amount of blood sugar in their body. Diabetics do not produce insulin, called Type 1 diabetes or do not produce enough or produce ineffective insulin, called Type 2 diabetes. In order to manage the condition, medication and even injections are used to help the body have more insulin in the body. If the hormone is not present, then the build up in the body causes organ damage, neuropathy and blood thickening, leading to a whole host of other debilitating conditions.
The device is in essence an artificial pancreas made up of a metal casing containing a dose of insulin held together by a gel barrier. When the glucose level in the body increases, the gel barrier liquefies which allows for the insulin to be dissipated into the body. As the insulin spreads to the liver, the process itself is akin to the normal processing of the pancreas, the main source of insulin in the body.
When the blood glucose level decreases because of the insulin dissipation, the protective gel hardens to stop the supply of insulin. This system, according to Professor Taylor, releases the correct amount of insulin needed by the body to manage the blood glucose levels. This removes the errors and guesses done by diabetics as to the proper dosages needed to manage the condition.
The device is undergoing pre-clinical trials and is designed to fit between the lowest rib and the hip of the individual. Every few weeks, the insulin in the device is replenished in order for the body to gain its needed hormone.
Professor Taylor is hoping that the device would be moved to clinical trials in the next few years and is looking forward to having the device available in the market in the next five to ten years.http://bcca0okcyrlcu3fso4ih-mbk9m.hop.clickbank.net/http://bcca0okcyrlcu3fso4ih-mbk9m.hop.clickbank.net/

No comments: